Indorama's Avgol to add new Reicofil 5, meltblown nonwovens line at its Mocksville, North Carolina, facility; high-speed, high-capacity flexible multiple beam line to produce baby diaper, adult incontinence, feminine hygiene, filtration, medical materials

Sample article from our Tissue & Hygiene

MOCKSVILLE, North Carolina , December 8, 2022 (press release) –

Avgol® has announced a significant investment in a new high-speed, high-capacity flexible multiple beam production line at its facility in Mocksville, USA.

“The addition of this new line enables us to have even greater production capacity, delivering component materials that are ‘Made in America’ and offering more sustainable options for the growing North America market and around the world,” said Avgol CEO Tommi Bjornman. “This additional new line also enables the Mocksville facility to deliver additional meltblown nonwovens, ensuring we have extra capacity to meet market demand.”

“Serving the growing baby diaper, adult incontinence and feminine hygiene markets along with satisfying sustained demand for meltblown filtration and medical materials, this investment enables Avgol to deliver an improved degree of service across the entire domestic region while consolidating and strengthening our existing position,” he said.

Avgol, an Indorama Ventures Limited company, leads the global hygiene market with the most comprehensive range of ultra-lightweight spun-melt nonwoven fabrics. This new, sixth line at the company’s facility in Mocksville will see Avgol investing in new Reicofil 5 (RF5) technology and underlines the company’s commitment to the region as a domestic supplier. The investment will deliver biocomponent and corresponding high-loft capabilities, with the line producing materials for applications that meet the needs of upper tier products for Hygiene customers.

As part of the investment, Avgol is also introducing extra capacity for meltblown production, ensuring a continuous supply of this critical material for both the region and customers worldwide.

Another aspect of the investment includes the addition of cutting-edge lamination capabilities, which enables Avgol to offer enhanced performance products into the existing markets the company serves, as well as to explore new opportunities in other markets.

“The RF5 line, meltblown line and lamination capabilities will provide us a powerful set of platforms as a base from which to provide high-value products for our customers,” said Mr. Bjornman. “It will enable us to further diversify the Avgol innovation portfolio while remaining true to our roots.”

Mr. Bjornman further commented that the investment will also significantly support further sustainable product development in Avgol, under its innovative FIT™ (Forward Innovative Thinking) strategy. “Avgol is committed to the future of nonwoven fabrics with a particular focus on bringing polyolefins forward as viable resins in single use articles,” he said. “We are excited to bring new assets, new capabilities, and new technologies that will challenge customer expectations of the nonwoven fabric industry.”

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.